New series of cyanoaryl porphyrazines with 4-(2-propinyloxy)phenyl and 4-benzyleoxyphenyl fragments in a macrocycle framing was reported. All the compounds reported on exhibit a good potential as the effective photosensitizer for photodynamic therapy (PDT). Moreover, they demonstrate unique combination of photodynamic activity and double sensory capacity toward environmental rigidity and polarity that is the promising platform for specifically personalized medicine.
No takes yet. Share an insight, caveat, or question.
Лермонтова et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: